BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35233792)

  • 1. Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition.
    Vernon-Roberts A; Lopez RN; Frampton CM; Day AS
    JPEN J Parenter Enteral Nutr; 2022 Sep; 46(7):1535-1552. PubMed ID: 35233792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
    Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
    Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition.
    Williams TJ; Moy N; Kaazan P; Callaghan G; Holtmann G; Martin N
    JPEN J Parenter Enteral Nutr; 2024 Feb; 48(2):165-173. PubMed ID: 38062902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
    Al-Amin AH; Sarveswaran J; Wood JM; Burke DA; Donnellan CF
    J Vasc Access; 2013; 14(4):379-82. PubMed ID: 23817948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
    Klek S; Szczepanek K; Hermanowicz A; Galas A
    JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
    Lambe C; Poisson C; Talbotec C; Goulet O
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1017-1025. PubMed ID: 29385236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Catheter Lock Solutions in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Individual-Patient Data Meta-Analysis.
    Wouters Y; Causevic E; Klek S; Groenewoud H; Wanten GJA
    JPEN J Parenter Enteral Nutr; 2020 Sep; 44(7):1198-1209. PubMed ID: 31985068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.
    Demirok A; Illy DHC; Nagelkerke SQ; Lagerweij MF; Benninga MA; Tabbers MM
    JPEN J Parenter Enteral Nutr; 2024 May; 48(4):486-494. PubMed ID: 38605559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis.
    Sun Y; Wan G; Liang L
    PLoS One; 2020; 15(4):e0231110. PubMed ID: 32255798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Infectious and Noninfectious Catheter Complications in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Meta-Analysis.
    Reitzel RA; Rosenblatt J; Chaftari AM; Raad II
    JPEN J Parenter Enteral Nutr; 2019 Sep; 43(7):832-851. PubMed ID: 31172542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of taurolidine locks to prevent recurrent catheter-related blood stream infections in adult patients receiving home parenteral nutrition: a 2-year mirror-image study.
    Lannoy D; Janes A; Lenne X; Neuville S; Bourry J; Odou P; Bruandet A; Seguy D
    Clin Nutr; 2021 Jun; 40(6):4309-4315. PubMed ID: 33583660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurolidine-related adverse events in patients on home parenteral nutrition frequently indicate catheter-related problems.
    Korzilius JW; Gillis VELM; Wouters Y; Wanten GJA
    Clin Nutr; 2022 Oct; 41(10):2178-2184. PubMed ID: 36067590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
    Chu HP; Brind J; Tomar R; Hill S
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
    Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition.
    Wouters Y; Theilla M; Singer P; Tribler S; Jeppesen PB; Pironi L; Vinter-Jensen L; Rasmussen HH; Rahman F; Wanten GJA
    Aliment Pharmacol Ther; 2018 Aug; 48(4):410-422. PubMed ID: 29978597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.
    Olthof ED; Rentenaar RJ; Rijs AJ; Wanten GJ
    Clin Nutr; 2013 Aug; 32(4):538-42. PubMed ID: 23267744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 2% taurolidine lock solution for treatment and prevention of catheter-related bloodstream infections in neonates: a feasibility study.
    Savarese I; Yazami S; De Rose DU; Carkeek K; Campi F; Auriti C; Danhaive O; Piersigilli F
    J Hosp Infect; 2024 Jan; 143():76-81. PubMed ID: 37972710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
    Neusser MA; Bobe I; Hammermeister A; Wittmann U
    Br J Nurs; 2021 Jul; 30(14):S24-S32. PubMed ID: 34288746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central Catheter-related Bloodstream Infection Rates in Children on Home Parenteral Nutrition.
    Trivić I; Mišak Z; Kerman V; Prlić H; Kolaček S; Hojsak I
    J Pediatr Gastroenterol Nutr; 2020 Mar; 70(3):e59-e62. PubMed ID: 31738292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.